Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK.

J Immunol. 2011 Nov 1;187(9):4392-402.

2.

An RNA interference-based screen of transcription factor genes identifies pathways necessary for sensory regeneration in the avian inner ear.

Alvarado DM, Hawkins RD, Bashiardes S, Veile RA, Ku YC, Powder KE, Spriggs MK, Speck JD, Warchol ME, Lovett M.

J Neurosci. 2011 Mar 23;31(12):4535-43. doi: 10.1523/JNEUROSCI.5456-10.2011.

3.

Semaphorin 7A promotes axon outgrowth through integrins and MAPKs.

Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL.

Nature. 2003 Jul 24;424(6947):398-405.

PMID:
12879062
4.

A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.

Born TL, Morrison LA, Esteban DJ, VandenBos T, Thebeau LG, Chen N, Spriggs MK, Sims JE, Buller RM.

J Immunol. 2000 Mar 15;164(6):3246-54.

5.

New lessons for immunology at the host-pathogen interface.

Spriggs MK, Sher A.

Curr Opin Immunol. 1999 Aug;11(4):363-4. No abstract available.

PMID:
10448149
6.

Shared resources between the neural and immune systems: semaphorins join the ranks.

Spriggs MK.

Curr Opin Immunol. 1999 Aug;11(4):387-91. Review.

PMID:
10448143
7.

Virus-encoded modulators of cytokines and growth factors.

Spriggs MK.

Cytokine Growth Factor Rev. 1999 Mar;10(1):1-4. Review. No abstract available.

PMID:
10379907
8.

Plexin A is a neuronal semaphorin receptor that controls axon guidance.

Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, Tessier-Lavigne M, Goodman CS.

Cell. 1998 Dec 23;95(7):903-16.

9.

A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR.

Comeau MR, Johnson R, DuBose RF, Petersen M, Gearing P, VandenBos T, Park L, Farrah T, Buller RM, Cohen JI, Strockbine LD, Rauch C, Spriggs MK.

Immunity. 1998 Apr;8(4):473-82.

10.

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK.

J Virol. 1998 May;72(5):4015-21.

11.

Molecular characterization of the human interleukin (IL)-17 receptor.

Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, VandenBos T, Zappone JD, Painter SL, Armitage RJ.

Cytokine. 1997 Nov;9(11):794-800.

PMID:
9367539
12.

Interleukin-17 and its receptor.

Spriggs MK.

J Clin Immunol. 1997 Sep;17(5):366-9. Review. No abstract available.

PMID:
9327335
13.

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, Hutt-Fletcher LM.

J Virol. 1997 Jun;71(6):4657-62.

14.

The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.

Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, Macduff B, Ulrich D, Alderson MR, Müllberg J, Cohen JI.

J Virol. 1996 Aug;70(8):5557-63.

15.

Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation.

Yao Z, Maraskovsky E, Spriggs MK, Cohen JI, Armitage RJ, Alderson MR.

J Immunol. 1996 May 1;156(9):3260-6.

PMID:
8617948
16.

One step ahead of the game: viral immunomodulatory molecules.

Spriggs MK.

Annu Rev Immunol. 1996;14:101-30. Review.

PMID:
8717509
17.

Human IL-17: a novel cytokine derived from T cells.

Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ.

J Immunol. 1995 Dec 15;155(12):5483-6.

PMID:
7499828
18.

Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.

Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK.

Immunity. 1995 Dec;3(6):811-21.

19.

Structural characteristics of CD40 ligand that determine biological function.

Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ.

Semin Immunol. 1994 Oct;6(5):267-78. Review.

PMID:
7532457
20.

Cytokine and cytokine receptor genes 'captured' by viruses.

Spriggs MK.

Curr Opin Immunol. 1994 Aug;6(4):526-9. Review.

PMID:
7946038
21.

Poxvirus-encoded soluble cytokine receptors.

Spriggs MK.

Virus Res. 1994 Jul;33(1):1-10. Review. No abstract available.

PMID:
7941696
22.

Inhibition of human B-cell lymphoma growth by CD40 stimulation.

Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsarfaty G, Tsarfaty I, Armitage RJ, Fanslow WC, Spriggs MK, Murphy WJ.

Blood. 1994 May 15;83(10):2787-94.

PMID:
7514045
23.

Recombinant CD40 ligand exerts potent biologic effects on T cells.

Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F.

J Immunol. 1994 May 1;152(9):4262-9.

PMID:
7908915
24.

The role of CD40 ligand in human disease.

Spriggs MK.

Adv Exp Med Biol. 1994;365:239-44. Review. No abstract available.

PMID:
7534036
25.

CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.

Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF.

J Immunol. 1994 Jan 1;152(1):117-28.

PMID:
7504707
26.

CD40L: a multi-functional ligand.

Armitage RJ, Maliszewski CR, Alderson MR, Grabstein KH, Spriggs MK, Fanslow WC.

Semin Immunol. 1993 Dec;5(6):401-12. Review.

PMID:
7510138
27.

The biology of the human ligand for CD40.

Spriggs MK, Fanslow WC, Armitage RJ, Belmont J.

J Clin Immunol. 1993 Nov;13(6):373-80. Review. No abstract available.

PMID:
7507124
28.

CD40 ligand and its role in X-linked hyper-IgM syndrome.

Callard RE, Armitage RJ, Fanslow WC, Spriggs MK.

Immunol Today. 1993 Nov;14(11):559-64. Review.

PMID:
7506037
29.

Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.

Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan IC, Gregory CD, Gordon J, et al.

Eur J Immunol. 1993 Sep;23(9):2368-71.

PMID:
8103750
30.

CD40 ligand is a T cell growth factor.

Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR.

Eur J Immunol. 1993 Sep;23(9):2326-31.

PMID:
7690330
31.

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK.

J Exp Med. 1993 Aug 1;178(2):669-74.

32.

Identification of a distinct low-affinity receptor for human interleukin-4 on pre-B cells.

Fanslow WC, Spriggs MK, Rauch CT, Clifford KN, Macduff BM, Ziegler SF, Schooley KA, Mohler KM, March CJ, Armitage RJ.

Blood. 1993 Jun 1;81(11):2998-3005.

PMID:
8499634
33.

Dinucleotide repeat polymorphism in the human CD40 ligand gene.

Allen RC, Spriggs MK, Belmont JW.

Hum Mol Genet. 1993 Jun;2(6):828. No abstract available.

PMID:
8102576
34.

Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines.

Maliszewski CR, Grabstein K, Fanslow WC, Armitage R, Spriggs MK, Sato TA.

Eur J Immunol. 1993 May;23(5):1044-9.

PMID:
8097470
35.

Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.

Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC.

J Immunol. 1993 May 1;150(9):3671-80.

PMID:
8097223
36.

The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.

Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, Armitage RJ.

J Immunol. 1993 Apr 15;150(8 Pt 1):3141-7.

PMID:
7682232
37.

Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.

Slack J, McMahan CJ, Waugh S, Schooley K, Spriggs MK, Sims JE, Dower SK.

J Biol Chem. 1993 Feb 5;268(4):2513-24.

38.

Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.

Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC.

J Exp Med. 1992 Dec 1;176(6):1543-50.

39.

Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein.

Spriggs MK, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RM, VanSlyke J.

Cell. 1992 Oct 2;71(1):145-52.

PMID:
1339315
40.

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Spriggs MK, Koller BH, Sato T, Morrissey PJ, Fanslow WC, Smithies O, Voice RF, Widmer MB, Maliszewski CR.

Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6070-4.

41.

Molecular characterization of the interleukin-1 receptor (IL-1R) on monocytes and polymorphonuclear cells.

Spriggs MK, Nevens PJ, Grabstein K, Dower SK, Cosman D, Armitage RJ, McMahan CJ, Sims JE.

Cytokine. 1992 Mar;4(2):90-5.

PMID:
1385988
42.

Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA.

Spriggs MK, Lioubin PJ, Slack J, Dower SK, Jonas U, Cosman D, Sims JE, Bauer J.

J Biol Chem. 1990 Dec 25;265(36):22499-505.

44.

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.

Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Chanock RM.

Virus Res. 1988 Aug;11(1):1-15. Review.

PMID:
2845680
45.

Live viral vaccines for respiratory and enteric tract diseases.

Chanock RM, Murphy BR, Collins PL, Coelingh KV, Olmsted RA, Snyder MH, Spriggs MK, Prince GA, Moss B, Flores J, et al.

Vaccine. 1988 Apr;6(2):129-33. Review.

PMID:
2838984
48.
49.

Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus.

Collins PL, Olmsted RA, Spriggs MK, Johnson PR, Buckler-White AJ.

Proc Natl Acad Sci U S A. 1987 Aug;84(15):5134-8.

50.

Supplemental Content

Loading ...
Support Center